Low dose boosted atazanavir is non-inferior to standard dose in Thai treatment optimisation study: LASA
1 August 2015. Related: Conference reports, Treatment strategies.
Conference reports
HPTN 052: no HIV transmissions on effective ART but only limited data on viral failure and drug resistance
1 August 2015. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Dispersible tablet formulation of dolutegravir is bioequivalent to the granule formulation
1 August 2015. Related: Conference reports, Paediatric care.
New case of remission in a perinatally infected teenager
1 August 2015. Related: Conference reports, Cure-related research.
IAS 2015: accessing webcasts and abstracts online
1 August 2015. Related: Conference reports.
IAS Towards an HIV Cure symposium, 18 – 19 July 2015, Vancouver, Canada
1 August 2015. Related: Conference reports, Cure-related research.
Plenary talks at IAS Cure Workshop
1 August 2015. Related: Conference reports, Cure-related research.
21st Annual BHIVA Conference, 21-24 April 2015, Brighton
1 June 2015. Related: Conference reports.
BHIVA pregnancy audit 2013 to 2014
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy.
Transmitted drug resistance in HIV positive pregnant women
1 June 2015. Related: Conference reports, Pregnancy, Drug resistance.
Primary HIV infection and early use of ART
1 June 2015. Related: Conference reports, Antiretrovirals.
Rectal STIs and viral load in HIV positive men on and off ART
1 June 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Impact of age and HIV on use of non-HIV meds: early results on health care use in the POPPY study
1 June 2015. Related: Conference reports, Ageing and life expectancy.
Other short reports from BHIVA:
1 June 2015. Related: Conference reports, Antiretrovirals, Paediatric care, Basic science and immunology.
2015 Conference on Retroviruses and Opportunistic Infections (CROI), 23-26 February 2015, Seattle
1 June 2015. Related: Conference reports.
Elvitegravir in children and adolescents
1 June 2015. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
PK of ARVs in pregnancy: rilpivirine, etravirine and raltegravir
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
HIV and cardiovascular disease
1 June 2015. Related: Conference reports, Coinfections and complications.
5th International Workshop on HIV & Women , 21-22 February 2015, Seattle, Washington
1 June 2015. Related: Conference reports.
Pharmacokinetics in pregnancy: darunavir/r and etravirine
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Low prolactin and high 20alpha-HSD might contribute to ART-associated progesterone deficits in pregnancy
1 June 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Pregnancy rates among women using ART and hormonal contraceptives in Kenya
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy.
Adolescents at increased risk of vertical transmission and poor pregnancy outcome in South Africa
1 June 2015. Related: Conference reports, Women's health, Pregnancy.
Gender difference in virological response to ART
1 June 2015. Related: Conference reports, Antiretrovirals, Women's health.
2015 Conference on Retroviruses and Opportunistic Infections (CROI), 23-26 February 2015, Seattle
24 March 2015. Related: Conference reports.
Pre-CROI meetings and workshops
24 March 2015. Related: Conference reports, Meeting report.
CROI webcasts online
24 March 2015. Related: Conference reports.
Pipeline ART: tenofovir alafenamide (TAF)
24 March 2015. Related: Conference reports, Antiretrovirals.
Pipeline ART: maturation inhibitors and an attachment inhibitor
24 March 2015. Related: Conference reports, Antiretrovirals.
No HIV transmissions between gay couples when viral load is undetectable: preliminary results from “Opposites Attract” study in Australia, Thailand and Brazil
24 March 2015. Related: Conference reports, HIV prevention and transmission.
PrEP reduced HIV risk by at least 86% in PROUD: no transmissions likely from people taking meds
24 March 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Q&A on the PROUD study and PrEP results from CROI
24 March 2015. Related: Conference reports.
“On demand” PrEP dosing in IPERGAY: 86% reduced risk of HIV, no transmissions with active drug use
24 March 2015. Related: Conference reports, HIV prevention and transmission.
Other HIV PrEP studies at CROI 2015: implementation of oral PrEP and problems with tenofovir gel
24 March 2015. Related: Conference reports, HIV prevention and transmission.
Early HIV treatment and isoniazid prophylaxis: why TEMPRANO results do not yet support universal ART at CD4 counts >500
24 March 2015. Related: Conference reports, Treatment strategies, TB coinfection.
Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART
24 March 2015. Related: Conference reports, Women's health, PK and drug interactions.
Three drug ART best for preventing vertical transmission to infants: results from the PROMISE study
24 March 2015. Related: Conference reports, Pregnancy.
3 in 5 breastfeeding women with viral load >1,000 copies/mL are undiagnosed in Kenya, Malawi and South Africa
24 March 2015. Related: Conference reports, Pregnancy.
Point of care HIV PCR test for infant diagnosis: good performance but poorer results in youngest age group
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Diagnostics.
Weekend-off ART is non-inferior to continuous ART in young people taking efavirenz-based regimens: results from BREATHER study
24 March 2015. Related: Conference reports, Treatment strategies, Paediatric care.
Increased cardiovascular risks in HIV positive children in Uganda and Zambia partially reversed by ART
24 March 2015. Related: Conference reports, Paediatric care, Coinfections and complications.
Lopinavir/ritonavir superior to nevirapine in children <3 years old: IMPAACT P1060 five year results
24 March 2015. Related: Conference reports, Paediatric care.
Long-term safety and efficacy of tenofovir in children
24 March 2015. Related: Conference reports, Paediatric care.
UK case of HIV remission: ten years off-ART in patient with prior progression and treated during seroconversion
24 March 2015. Related: Conference reports, Cure-related research.
XXIV International HIV Drug Resistance Workshop , 21-22 February 2015, Seattle, Washington
24 March 2015. Related: Conference reports, Drug resistance.
Prevalence of transmitted drug resistance globally: highest in Australia, US and some European countries but between-country differences in all regions
24 March 2015. Related: Conference reports, Drug resistance.
Higher rates of K65R in non-B subtype in large UK cohort and implications of tenofovir resistance in resource-limited settings
24 March 2015. Related: Conference reports, Drug resistance.
Drug resistance and integrase inhibitors: potential impact of HIV subtype
24 March 2015. Related: Conference reports, Drug resistance.
Drug resistance in children after PMTCT and early treatment
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Drug resistance.
Five Nations Conference on HIV and Hepatitis – 8-9 December 2014, London
29 January 2015. Related: Conference reports.
Summary of the pre-conference clinical course
29 January 2015. Related: Conference reports, Hepatitis coinfection.
Hepatitis C drug access: Europe is the new Africa
29 January 2015. Related: Conference reports, Treatment access, Hepatitis coinfection.
45th Union World Conference on Lung Health, 28 October – 1 November 2014, Barcelona, Spain
29 January 2015. Related: Conference reports.
Good outcomes within the National Bedaquiline Clinical Access programme in South Africa
29 January 2015. Related: Conference reports, TB coinfection.
Pharmacokinetics and safety of moxifloxacin in children
29 January 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
TB in the ARROW trial of children on ART
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
Problems giving current second line TB drugs to children
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
12th Glasgow Congress on HIV Therapy, 2-6 November 2014, Glasgow
1 December 2014. Related: Conference reports.
Savings to the NHS predicted from switching to generic antiretrovirals
1 December 2014. Related: Conference reports, Antiretrovirals, Treatment access.
Lower dose efavirenz effective in two studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Should tenofovir dose be 200 – 250 mg when used with protease inhibitors?
1 December 2014. Related: Conference reports, Antiretrovirals.
3TC inferior to FTC in Dutch cohort but interchangeable in other studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Suicide not associated with efavirenz use in the D:A:D cohort study
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Gender differences in use of cardiovascular disease-related interventions: D:A:D study
1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.
Efavirenz decreases exposure to hormonal contraceptive implant
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.